<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30232">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02068417</url>
  </required_header>
  <id_info>
    <org_study_id>STU10/002</org_study_id>
    <nct_id>NCT02068417</nct_id>
  </id_info>
  <brief_title>Pilot Study of the Treatment of Erectile Dysfunction With Extracorporeal Shockwave Therapy (ESWT)</brief_title>
  <official_title>A Prospective, Randomised, Blinded, Placebo-controlled Pilot Study of the Treatment of Erectile Dysfunction With Extracorporeal Shockwave Therapy (ESWT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Storz Medical AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Storz Medical AG</source>
  <oversight_info>
    <authority>Austria: Federal Office for Safety in Health Care</authority>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <authority>Pakistan: Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the pilot study is to assess the feasibility of a full randomised,
      placebo-controlled clinical trial.The aim is to demonstrate that penile shockwave
      application in patients with erectile dysfunction of vascular origin leads to a greater
      increase in potency than in the control group.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    It has been decided to improve the inclusion criteria for better study outcome
  </why_stopped>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Effects of erection problems on the sex life (International Index of Erectile Function Questionnaire)</measure>
    <time_frame>up to 6 months post treatment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of erection (Quality of Erection Questionnaire)</measure>
    <time_frame>At screening, 1, 3 and 6 months post treatment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Shock wave tratment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Shock waves are applied extracorporealy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Shock wave treatment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Shock waves are prohibited to enter the body by placebo stand-off</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>shock waves</intervention_name>
    <description>shockwaves are applied extracorporealy with 0.1mJ/mm2</description>
    <arm_group_label>Shock wave tratment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>placebo shockwave traetment</intervention_name>
    <description>shock waves are applied extracoporealy with 0.1mJ/mm2 through placebo stand-off which prohibits the shock waves to enter the body</description>
    <arm_group_label>Placebo Shock wave treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Erectile dysfunction for more than 6 months

          -  Informed consent

          -  Positive effect of PDE-5-Hammer

          -  IIEF-15 score less than 20

          -  No neurological desease

          -  Stable partnership for more than 3 months

          -  Age 18-75

        Exclusion Criteria:

          -  Total prostatectomy

          -  Another reason for DE except for vascular disorder

          -  Clinically significant hematological desease

          -  Heart stroke, Arrythmia during the last 6 months

          -  Cancer dureing tha last 5 years

          -  Intake of antiandrogen

          -  ED treatment with the last 7 days

          -  IIEF score higher than, equal to 20

          -  Previous shockwave treatment
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bethanien Krankenhaus Chemnitz gemeinn√ºtzige GmbH</name>
      <address>
        <city>Chemnitz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 20, 2014</lastchanged_date>
  <firstreceived_date>February 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IIEF score</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
